_id
6915e733bc934aba376b1ad9
Ticker
PROK
Name
ProKidney Corp.
Exchange
NASDAQ
Address
2000 Frontis Plaza Blvd., Winston-Salem, NC, United States, 27103
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://prokidney.com
Description
ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2 and 3 trials of rilparencel. ProKidney Corp. was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Last Close
2.22
Volume
1083753
Current Price
2.21
Change
-0.45045045045046084
Last Updated
2025-12-03T12:22:18.932Z
Image
data:image/webp;base64,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
Ipo Date
2022-07-12T00:00:00.000Z
Market Cap
676877312
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9983333333333334
Sentiment Sources
6
Rating
4.1429
Target Price
5.4
Strong Buy
4
Buy
0
Hold
3
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
217000
Cost Of Revenue
1398000
Gross Profit
-1181000
Operating Expenses
37358000
Operating Income
-38539000
Interest Expense
2000
Pretax Income
-35283000
Net Income
-16469000
Eps
-0.12199910282619822
Dividends Per Share
-
Shares Outstanding
141545448
Income Tax Expense
560000
EBITDA
-33883000
Operating Margin
-17759.907834101385
Total Other Income Expense Net
3256000
Cash
95323000
Short Term Investments
176402000
Receivables
1237000
Inventories
-
Total Current Assets
299989000
Property Plant Equipment
51619000
Total Assets
351608000
Payables
1942000
Short Term Debt
991000
Long Term Debt
-
Total Liabilities
33270000
Equity
-1008020000
Depreciation
1673000
Change In Working Capital
1131000
Cash From Operations
-26596000
Capital Expenditures
5197000
Cash From Investing
29018000
Cash From Financing
7961000
Net Change In Cash
10383000
PE
-
PB
-0.2959604761413464
ROE
1.6337969484732446
ROA
-4.683909353598326
FCF
-31793000
Fcf Percent
-146.5115207373272
Piotroski FScore
0
Health Score
16
Deep Value Investing Score
1.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
1
Growth Investing Score
1
Momentum Investing Score
2.5
Net Net Investing Score
0.5
Quality Investing Score
1
Value Investing Score
1
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
217000
Quarters > 0 > income Statement > cost Of Revenue
1398000
Quarters > 0 > income Statement > gross Profit
-1181000
Quarters > 0 > income Statement > operating Expenses
37358000
Quarters > 0 > income Statement > operating Income
-38539000
Quarters > 0 > income Statement > interest Expense
2000
Quarters > 0 > income Statement > pretax Income
-35283000
Quarters > 0 > income Statement > net Income
-16469000
Quarters > 0 > income Statement > eps
-0.12199910282619822
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
134992796
Quarters > 0 > income Statement > income Tax Expense
560000
Quarters > 0 > income Statement > EBITDA
-33883000
Quarters > 0 > income Statement > operating Margin
-17759.907834101385
Quarters > 0 > income Statement > total Other Income Expense Net
3256000
Quarters > 0 > balance Sheet > cash
95323000
Quarters > 0 > balance Sheet > short Term Investments
176402000
Quarters > 0 > balance Sheet > receivables
1237000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
299989000
Quarters > 0 > balance Sheet > property Plant Equipment
51619000
Quarters > 0 > balance Sheet > total Assets
351608000
Quarters > 0 > balance Sheet > payables
1942000
Quarters > 0 > balance Sheet > short Term Debt
991000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
33270000
Quarters > 0 > balance Sheet > equity
-1008020000
Quarters > 0 > cash Flow > net Income
-16469000
Quarters > 0 > cash Flow > depreciation
1673000
Quarters > 0 > cash Flow > change In Working Capital
1131000
Quarters > 0 > cash Flow > cash From Operations
-26596000
Quarters > 0 > cash Flow > capital Expenditures
5197000
Quarters > 0 > cash Flow > cash From Investing
29018000
Quarters > 0 > cash Flow > cash From Financing
7961000
Quarters > 0 > cash Flow > net Change In Cash
10383000
Quarters > 0 > ratios > PE
-0.12199910282619822
Quarters > 0 > ratios > PB
-0.2959604761413464
Quarters > 0 > ratios > ROE
1.6337969484732446
Quarters > 0 > ratios > ROA
-4.683909353598326
Quarters > 0 > ratios > FCF
-31793000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-146.5115207373272
Quarters > 0 > health Score
16
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
221000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
221000
Quarters > 1 > income Statement > operating Expenses
39930000
Quarters > 1 > income Statement > operating Income
-39709000
Quarters > 1 > income Statement > interest Expense
1000
Quarters > 1 > income Statement > pretax Income
-36117000
Quarters > 1 > income Statement > net Income
-16552000
Quarters > 1 > income Statement > eps
-0.12661128774205077
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
130730840
Quarters > 1 > income Statement > income Tax Expense
848000
Quarters > 1 > income Statement > EBITDA
-34651000
Quarters > 1 > income Statement > operating Margin
-17967.87330316742
Quarters > 1 > income Statement > total Other Income Expense Net
3592000
Quarters > 1 > balance Sheet > cash
84940000
Quarters > 1 > balance Sheet > short Term Investments
209788000
Quarters > 1 > balance Sheet > receivables
1775000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
324440000
Quarters > 1 > balance Sheet > property Plant Equipment
47693000
Quarters > 1 > balance Sheet > total Assets
372133000
Quarters > 1 > balance Sheet > payables
2443000
Quarters > 1 > balance Sheet > short Term Debt
903000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
32680000
Quarters > 1 > balance Sheet > equity
-1002500000
Quarters > 1 > cash Flow > net Income
-36965000
Quarters > 1 > cash Flow > depreciation
1465000
Quarters > 1 > cash Flow > change In Working Capital
-1891000
Quarters > 1 > cash Flow > cash From Operations
-31416000
Quarters > 1 > cash Flow > capital Expenditures
3112000
Quarters > 1 > cash Flow > cash From Investing
18565000
Quarters > 1 > cash Flow > cash From Financing
-14000
Quarters > 1 > cash Flow > net Change In Cash
-12865000
Quarters > 1 > ratios > PE
-0.12661128774205077
Quarters > 1 > ratios > PB
-0.28819466972568575
Quarters > 1 > ratios > ROE
1.651072319201995
Quarters > 1 > ratios > ROA
-4.447872131737847
Quarters > 1 > ratios > FCF
-34528000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-156.23529411764707
Quarters > 1 > health Score
16
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
230000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
230000
Quarters > 2 > income Statement > operating Expenses
41618000
Quarters > 2 > income Statement > operating Income
-41388000
Quarters > 2 > income Statement > interest Expense
0
Quarters > 2 > income Statement > pretax Income
-37361000
Quarters > 2 > income Statement > net Income
-16734000
Quarters > 2 > income Statement > eps
-0.12974470066864807
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
128976366
Quarters > 2 > income Statement > income Tax Expense
591000
Quarters > 2 > income Statement > EBITDA
-35761000
Quarters > 2 > income Statement > operating Margin
-17994.782608695652
Quarters > 2 > income Statement > total Other Income Expense Net
4027000
Quarters > 2 > balance Sheet > cash
97805000
Quarters > 2 > balance Sheet > short Term Investments
230693000
Quarters > 2 > balance Sheet > receivables
1752000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
359662000
Quarters > 2 > balance Sheet > property Plant Equipment
46399000
Quarters > 2 > balance Sheet > total Assets
406061000
Quarters > 2 > balance Sheet > payables
3122000
Quarters > 2 > balance Sheet > short Term Debt
857000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
36084000
Quarters > 2 > balance Sheet > equity
-998553000
Quarters > 2 > cash Flow > net Income
-37952000
Quarters > 2 > cash Flow > depreciation
1600000
Quarters > 2 > cash Flow > change In Working Capital
1113000
Quarters > 2 > cash Flow > cash From Operations
-29592000
Quarters > 2 > cash Flow > capital Expenditures
1135000
Quarters > 2 > cash Flow > cash From Investing
28289000
Quarters > 2 > cash Flow > cash From Financing
-12000
Quarters > 2 > cash Flow > net Change In Cash
-1315000
Quarters > 2 > ratios > PE
-0.12974470066864807
Quarters > 2 > ratios > PB
-0.2854508161910284
Quarters > 2 > ratios > ROE
1.675824918657297
Quarters > 2 > ratios > ROA
-4.121055703453422
Quarters > 2 > ratios > FCF
-30727000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-133.59565217391304
Quarters > 2 > health Score
16
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
76000
Quarters > 3 > income Statement > cost Of Revenue
-1720000
Quarters > 3 > income Statement > gross Profit
76000
Quarters > 3 > income Statement > operating Expenses
51647000
Quarters > 3 > income Statement > operating Income
-51571000
Quarters > 3 > income Statement > interest Expense
2000
Quarters > 3 > income Statement > pretax Income
-46781000
Quarters > 3 > income Statement > net Income
-21278000
Quarters > 3 > income Statement > eps
-0.16616373334470766
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
128054417
Quarters > 3 > income Statement > income Tax Expense
1702000
Quarters > 3 > income Statement > EBITDA
-45205000
Quarters > 3 > income Statement > operating Margin
-67856.57894736841
Quarters > 3 > income Statement > total Other Income Expense Net
4790000
Quarters > 3 > balance Sheet > cash
99120000
Quarters > 3 > balance Sheet > short Term Investments
259172000
Quarters > 3 > balance Sheet > receivables
2447000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
395884000
Quarters > 3 > balance Sheet > property Plant Equipment
45189000
Quarters > 3 > balance Sheet > total Assets
441073000
Quarters > 3 > balance Sheet > payables
3633000
Quarters > 3 > balance Sheet > short Term Debt
765000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
39436000
Quarters > 3 > balance Sheet > equity
-994954000
Quarters > 3 > cash Flow > net Income
-48483000
Quarters > 3 > cash Flow > depreciation
1574000
Quarters > 3 > cash Flow > change In Working Capital
17555000
Quarters > 3 > cash Flow > cash From Operations
-24171000
Quarters > 3 > cash Flow > capital Expenditures
25509000
Quarters > 3 > cash Flow > cash From Investing
15080000
Quarters > 3 > cash Flow > cash From Financing
123000
Quarters > 3 > cash Flow > net Change In Cash
-8968000
Quarters > 3 > ratios > PE
-0.16616373334470766
Quarters > 3 > ratios > PB
-0.28443552322016896
Quarters > 3 > ratios > ROE
2.1385913318605683
Quarters > 3 > ratios > ROA
-4.82414475608346
Quarters > 3 > ratios > FCF
-49680000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-653.6842105263158
Quarters > 3 > health Score
16
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
76000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
76000
Annuals > 0 > income Statement > operating Expenses
183752000
Annuals > 0 > income Statement > operating Income
-183676000
Annuals > 0 > income Statement > interest Expense
9000
Annuals > 0 > income Statement > pretax Income
-163933000
Annuals > 0 > income Statement > net Income
-61186000
Annuals > 0 > income Statement > eps
-0.6248813207024909
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
97916193
Annuals > 0 > income Statement > income Tax Expense
-598000
Annuals > 0 > income Statement > EBITDA
-158492000
Annuals > 0 > income Statement > operating Margin
-241678.94736842104
Annuals > 0 > income Statement > total Other Income Expense Net
19743000
Annuals > 0 > balance Sheet > cash
99120000
Annuals > 0 > balance Sheet > short Term Investments
259172000
Annuals > 0 > balance Sheet > receivables
2447000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
395884000
Annuals > 0 > balance Sheet > property Plant Equipment
45189000
Annuals > 0 > balance Sheet > total Assets
441073000
Annuals > 0 > balance Sheet > payables
3633000
Annuals > 0 > balance Sheet > short Term Debt
765000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
39436000
Annuals > 0 > balance Sheet > equity
-994954000
Annuals > 0 > cash Flow > net Income
-163335000
Annuals > 0 > cash Flow > depreciation
5432000
Annuals > 0 > cash Flow > change In Working Capital
3956000
Annuals > 0 > cash Flow > cash From Operations
-126351000
Annuals > 0 > cash Flow > capital Expenditures
29509000
Annuals > 0 > cash Flow > cash From Investing
20414000
Annuals > 0 > cash Flow > cash From Financing
144408000
Annuals > 0 > cash Flow > net Change In Cash
38471000
Annuals > 0 > ratios > PE
-0.6248813207024909
Annuals > 0 > ratios > PB
-0.2214287637920949
Annuals > 0 > ratios > ROE
6.149631038218852
Annuals > 0 > ratios > ROA
-13.87208013186026
Annuals > 0 > ratios > FCF
-155860000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-2050.7894736842104
Annuals > 0 > health Score
19
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
3169000
Annuals > 1 > income Statement > gross Profit
-3169000
Annuals > 1 > income Statement > operating Expenses
151522000
Annuals > 1 > income Statement > operating Income
-151522000
Annuals > 1 > income Statement > interest Expense
12000
Annuals > 1 > income Statement > pretax Income
-129451000
Annuals > 1 > income Statement > net Income
-35468000
Annuals > 1 > income Statement > eps
-0.5747135283640036
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
61714225
Annuals > 1 > income Statement > income Tax Expense
5996000
Annuals > 1 > income Statement > EBITDA
-125586000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
22071000
Annuals > 1 > balance Sheet > cash
60649000
Annuals > 1 > balance Sheet > short Term Investments
302301000
Annuals > 1 > balance Sheet > receivables
1375000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
374146000
Annuals > 1 > balance Sheet > property Plant Equipment
46406000
Annuals > 1 > balance Sheet > total Assets
420552000
Annuals > 1 > balance Sheet > payables
5098000
Annuals > 1 > balance Sheet > short Term Debt
803000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
29216000
Annuals > 1 > balance Sheet > equity
-1103396000
Annuals > 1 > cash Flow > net Income
-135447000
Annuals > 1 > cash Flow > depreciation
3853000
Annuals > 1 > cash Flow > change In Working Capital
16674000
Annuals > 1 > cash Flow > cash From Operations
-90069000
Annuals > 1 > cash Flow > capital Expenditures
34197000
Annuals > 1 > cash Flow > cash From Investing
-329983000
Annuals > 1 > cash Flow > cash From Financing
-9551000
Annuals > 1 > cash Flow > net Change In Cash
-429603000
Annuals > 1 > ratios > PE
-0.5747135283640036
Annuals > 1 > ratios > PB
-0.1258451238268038
Annuals > 1 > ratios > ROE
3.214439784084771
Annuals > 1 > ratios > ROA
-8.433677642717191
Annuals > 1 > ratios > FCF
-124266000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
18
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
3036000
Annuals > 2 > income Statement > gross Profit
-3036000
Annuals > 2 > income Statement > operating Expenses
153007000
Annuals > 2 > income Statement > operating Income
-153007000
Annuals > 2 > income Statement > interest Expense
215000
Annuals > 2 > income Statement > pretax Income
-147239000
Annuals > 2 > income Statement > net Income
-108032000
Annuals > 2 > income Statement > eps
-1.7554695236681839
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
61540231
Annuals > 2 > income Statement > income Tax Expense
896000
Annuals > 2 > income Statement > EBITDA
-143988000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
5768000
Annuals > 2 > balance Sheet > cash
490252000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
504719000
Annuals > 2 > balance Sheet > property Plant Equipment
13064000
Annuals > 2 > balance Sheet > total Assets
517996000
Annuals > 2 > balance Sheet > payables
3044000
Annuals > 2 > balance Sheet > short Term Debt
493000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
13057000
Annuals > 2 > balance Sheet > equity
-1096616000
Annuals > 2 > cash Flow > net Income
-148135000
Annuals > 2 > cash Flow > depreciation
3036000
Annuals > 2 > cash Flow > change In Working Capital
-6459000
Annuals > 2 > cash Flow > cash From Operations
-77089000
Annuals > 2 > cash Flow > capital Expenditures
1846000
Annuals > 2 > cash Flow > cash From Investing
-1738000
Annuals > 2 > cash Flow > cash From Financing
548521000
Annuals > 2 > cash Flow > net Change In Cash
469694000
Annuals > 2 > ratios > PE
-1.7554695236681839
Annuals > 2 > ratios > PB
-0.12626618593017064
Annuals > 2 > ratios > ROE
9.851397389788222
Annuals > 2 > ratios > ROA
-20.855759503934394
Annuals > 2 > ratios > FCF
-78935000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
23
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
1984000
Annuals > 3 > income Statement > gross Profit
-1984000
Annuals > 3 > income Statement > operating Expenses
55110000
Annuals > 3 > income Statement > operating Income
-55110000
Annuals > 3 > income Statement > interest Expense
2000
Annuals > 3 > income Statement > pretax Income
-55108000
Annuals > 3 > income Statement > net Income
-55146000
Annuals > 3 > income Statement > eps
-1.7292568203198495
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
31890000
Annuals > 3 > income Statement > income Tax Expense
38000
Annuals > 3 > income Statement > EBITDA
-53124000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
2000
Annuals > 3 > balance Sheet > cash
20558000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
27271000
Annuals > 3 > balance Sheet > property Plant Equipment
12599000
Annuals > 3 > balance Sheet > total Assets
40298000
Annuals > 3 > balance Sheet > payables
2834000
Annuals > 3 > balance Sheet > short Term Debt
267000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
13381000
Annuals > 3 > balance Sheet > equity
26917000
Annuals > 3 > cash Flow > net Income
-55146000
Annuals > 3 > cash Flow > depreciation
1984000
Annuals > 3 > cash Flow > change In Working Capital
2164000
Annuals > 3 > cash Flow > cash From Operations
-50299000
Annuals > 3 > cash Flow > capital Expenditures
5192000
Annuals > 3 > cash Flow > cash From Investing
-5191000
Annuals > 3 > cash Flow > cash From Financing
71470000
Annuals > 3 > cash Flow > net Change In Cash
15980000
Annuals > 3 > ratios > PE
-1.7292568203198495
Annuals > 3 > ratios > PB
2.665694542482446
Annuals > 3 > ratios > ROE
-204.87424304342977
Annuals > 3 > ratios > ROA
-136.84550101742022
Annuals > 3 > ratios > FCF
-55491000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.12199910282619822
Valuation > metrics > PB
-0.2959604761413464
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
1.6337969484732446
Profitability > metrics > ROA
-5.489867961825267
Profitability > metrics > Net Margin
-75.89400921658986
Profitability > final Score
3
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-19269.5
Risk > final Score
-77048
Risk > verdict
High
Liquidity > metrics > Current Ratio
102.28060006818957
Liquidity > metrics > Quick Ratio
102.28060006818957
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
3
Prev Profitabilities > 1
3
Prev Profitabilities > 2
4
Prev Risks > 0
-158806
Prev Risks > 1
-73
Prev Risks > 2
-103112
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-13T20:59:04.167Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-10
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.12
Earnings History > 0 > eps Estimate
-0.1461
Earnings History > 0 > eps Difference
0.0261
Earnings History > 0 > surprise Percent
17.8645
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.13
Earnings History > 1 > eps Estimate
-0.15
Earnings History > 1 > eps Difference
0.02
Earnings History > 1 > surprise Percent
13.3333
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.13
Earnings History > 2 > eps Estimate
-0.16
Earnings History > 2 > eps Difference
0.03
Earnings History > 2 > surprise Percent
18.75
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-17
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.16
Earnings History > 3 > eps Estimate
-0.15
Earnings History > 3 > eps Difference
-0.01
Earnings History > 3 > surprise Percent
-6.6667
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-10
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.1419
Earnings History > 4 > eps Estimate
-0.15
Earnings History > 4 > eps Difference
0.0081
Earnings History > 4 > surprise Percent
5.4
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-09
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.16
Earnings History > 5 > eps Estimate
-0.17
Earnings History > 5 > eps Difference
0.01
Earnings History > 5 > surprise Percent
5.8824
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-10
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.16
Earnings History > 6 > eps Estimate
-0.18
Earnings History > 6 > eps Difference
0.02
Earnings History > 6 > surprise Percent
11.1111
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-22
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.09
Earnings History > 7 > eps Estimate
-0.17
Earnings History > 7 > eps Difference
0.08
Earnings History > 7 > surprise Percent
47.0588
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-14
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.18
Earnings History > 8 > eps Estimate
-0.16
Earnings History > 8 > eps Difference
-0.02
Earnings History > 8 > surprise Percent
-12.5
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-10
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.14
Earnings History > 9 > eps Estimate
-0.39
Earnings History > 9 > eps Difference
0.25
Earnings History > 9 > surprise Percent
64.1026
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.16
Earnings History > 10 > eps Estimate
-0.39
Earnings History > 10 > eps Difference
0.23
Earnings History > 10 > surprise Percent
58.9744
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-28
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.11
Earnings History > 11 > eps Estimate
-0.24
Earnings History > 11 > eps Difference
0.13
Earnings History > 11 > surprise Percent
54.1667
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.13
Earnings History > 12 > eps Estimate
-0.24
Earnings History > 12 > eps Difference
0.11
Earnings History > 12 > surprise Percent
45.8333
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-12
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0558
Earnings History > 13 > eps Estimate
-0.06
Earnings History > 13 > eps Difference
0.0042
Earnings History > 13 > surprise Percent
7
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-16
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.12
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-24
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.06
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-15
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.01
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-16
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.01
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-09
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
0
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a cryopreserved version of rilparencel that allows for long-term product preservation to be used in Phase 2 and 3 trials of rilparencel. ProKidney Corp. was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AProKidney Corp. (NASDAQ:PROK) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
12/12/2025
ProKidney Corp. (NASDAQ:PROK) Receives Consensus Rating of "Hold" from Analysts MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
Target Price:
$5.4
Analyst Picks
Strong Buy
4
Buy
0
Hold
3
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 45.68% of the total shares of ProKidney Corp.
1.
Suvretta Capital Management, LLC(9.1421%)
since
2025/03/31
2.
Morgan Stanley - Brokerage Accounts(7.6576%)
since
2025/03/31
3.
BlackRock Inc(5.0112%)
since
2025/03/31
4.
Vanguard Group Inc(3.8608%)
since
2025/03/31
5.
NUMC B0-B(2.5427%)
since
2025/07/31
6.
Geode Capital Management, LLC(1.7203%)
since
2025/03/31
7.
Bleichroeder LP(1.4816%)
since
2025/03/31
8.
State Street Corp(1.2788%)
since
2025/03/31
9.
MS INVF US Growth I(1.1111%)
since
2025/03/31
10.
Brown University(0.7408%)
since
2025/03/31
11.
GBM104 A(0.7408%)
since
2025/07/31
12.
Vanguard Institutional Extnd Mkt Idx Tr(0.7358%)
since
2025/07/31
13.
Northern Trust Corp(0.672%)
since
2025/03/31
14.
BrighthouseI Morgan Stanley Discovery B(0.6292%)
since
2025/06/30
15.
Hennion & Walsh Asset Management Inc(0.6254%)
since
2025/03/31
16.
Charles Schwab Investment Management Inc(0.6116%)
since
2025/03/31
17.
Morgan Stanley Insight I(0.5891%)
since
2025/06/30
18.
Morgan Stanley Insight(0.5891%)
since
2025/06/30
19.
Bank of America Corp(0.5577%)
since
2025/03/31
20.
GBM103 A(0.5556%)
since
2025/07/31
21.
Morgan Stanley Inst Discovery I(0.5432%)
since
2025/06/30
22.
Morgan Stanley Discovery(0.5432%)
since
2025/06/30
23.
GBM102 A(0.5185%)
since
2025/07/31
24.
MS INVF Global Insight Z(0.4055%)
since
2025/06/30
25.
Fidelity Extended Market Index(0.3645%)
since
2025/07/31
26.
Marshall Wace Asset Management Ltd(0.3443%)
since
2025/06/30
27.
Schwab US Small-Cap ETFâ„¢(0.3239%)
since
2025/08/30
28.
Morgan Stanley Inst Inception I(0.2041%)
since
2025/06/30
29.
Morgan Stanley Inception(0.2041%)
since
2025/06/30
30.
UBS Group AG(0.184%)
since
2025/03/31
31.
Bank of New York Mellon Corp(0.1775%)
since
2025/03/31
32.
Goldman Sachs Group Inc(0.1615%)
since
2025/03/31
33.
Extended Equity Market Fund K(0.1395%)
since
2025/06/30
34.
Fidelity Total Market Index(0.1276%)
since
2025/07/31
35.
EQ/Morgan Stanley Small Cap Growth K(0.1225%)
since
2025/07/31
36.
Renaissance Technologies Corp(0.1174%)
since
2025/03/31
37.
Vanguard Total Stock Mkt Idx Inv(0.1119%)
since
2025/07/31
38.
Susquehanna International Group, LLP(0.1015%)
since
2025/03/31
39.
BNP Paribas Arbitrage, SA(0.071%)
since
2025/03/31
40.
Citigroup Inc(0.0584%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.12
EPS Estimate
-0.1461
EPS Difference
0.0261
Surprise Percent
17.8645%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.